Intercure Ltd. SEC filings INCR
Intercure Ltd. has 119 filings in SEC EDGAR's recent list, going back to Apr 21, 2021. Its latest annual report, Form 20-F, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Sep 8, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| D | Filing | Aug 19, 2026 | — |
| UPLOAD | Letter from the SEC | Aug 29, 2025 | — |
| CORRESP | Letter to the SEC | Aug 7, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2025 | — |
| NT 20-F | Filing | May 1, 2025 | Dec 31, 2024 |
| NT 20-F | Filing | May 1, 2024 | Dec 31, 2023 |
| EFFECT | Filing | Jun 24, 2022 | — |
| EFFECT | Filing | Oct 4, 2021 | — |
| CORRESP | Letter to the SEC | Sep 30, 2021 | — |
| CORRESP | Letter to the SEC | Sep 23, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 16, 2021 | — |
| SEC STAFF ACTION | Filing | Aug 31, 2021 | — |
| CERT | 20f cert | Aug 30, 2021 | — |
| CORRESP | Letter to the SEC | Aug 27, 2021 | — |
| 20FR12B/A | Filing | Aug 16, 2021 | — |
| 20FR12B/A | Filing | Aug 3, 2021 | — |
| CORRESP | Letter to the SEC | Aug 2, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2021 | — |
| 20FR12B | Filing | Jul 14, 2021 | — |
| DRSLTR | Filing | Jul 2, 2021 | — |
| DRS/A | Filing | Jul 2, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 24, 2021 | — |
| DRSLTR | Filing | Jun 10, 2021 | — |
| DRS/A | Filing | Jun 10, 2021 | — |
| UPLOAD | Letter from the SEC | May 18, 2021 | — |
| DRS | Filing | Apr 21, 2021 | — |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- INCR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Herzliya, Israel
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1857030
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.